NCT04456842

Cardiovascular Registry of Atrial Fibrillation

Cardiovascular Registry of Atrial Fibrillation in Latin America: The LACROSS Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,016 (actual)
• Sponsor: Brazilian Clinical Research Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Follow a representative sample of Latin American patients diagnosed with atrial fibrillation to set data on demographic characteristics, documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death

Detailed description

Patients will be followed 6 months and 1 year after the baseline visit and will be collected data of antithrombotic therapy, laboratory data, discontinuation rates of antithrombotic therapy and clinical outcomes.

Conditions

• Atrial Fibrillation
• Atrial Flutter

Interventions

Type	Name	Description
OTHER	Patient Registry Data	To set data on demographic characteristics,documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death.

Timeline

• Start date: 2020-08-04
• Primary completion: 2024-09-13
• Completion: 2024-09-30
• First posted: 2020-07-07
• Last updated: 2024-10-04

Locations

17 sites across 4 countries: Argentina, Brazil, Colombia, Mexico